Skip to content
Screener

Alamar Biosciences ALMR Service — Revenue

Other product segments

Consumables
$13.96M+178%
Instruments
$7.38M+78.0%

Similar metrics at other companies

Ribbon Communications Inc. logo
RBBNService Revenue Professional Services — Revenue
$30.83M-6.2%
GigaCloud Technology logo
GCTService revenues — Revenue
$120.83M+24.7%
Itron logo
ITRIService revenues — Revenue
$109.44M+22.2%
Seaboard logo
SEBProduct And Service Other Services — Revenue
$23M+15.0%
Bakkt logo
BKKTService revenue — Revenue
$197K+1,213%
Eos Energy Enterprises, Inc. logo
EOSEService revenue — Revenue
$1.03M-13.0%

Other financials

Income statement

See full
Revenue$26.0M+98.9%
Gross profit$14.5M+126%
Operating income-$12.3M-44.4%
Net income-$21.3M-178%
EPS (diluted)-$1.74-156%

Balance sheet

See full
Cash & equivalents$64.6M—
Total debt$30.6M—
Total equity-$178.1M—
Total assets$186.5M—

Cash flow

See full
Operating cash flow-$20.3M-55.7%
CapEx$600.0K+8.3%
Free cash flow-$20.9M-53.8%

Valuation

See full
Market cap$1.96B+37.6%
Enterprise value$1.93B—

Returns & leverage

See full
Debt / equity-0.2×—
Current ratio5.9×—

Where this comes from

Reported directly by Alamar Biosciences in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Alamar Biosciences’s 10-Q, filed May 8, 2026.

Filed
May 8, 2026, 8:30 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-213424
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Instruments$7,381$4,146
Consumables13,9605,023
Services4,6943,672
Other revenue—250
Total$26,035$13,091

Item 1. Financial Statements

FAQ

What is Alamar Biosciences's service — revenue?
Alamar Biosciences (ALMR) reported service — revenue of $4.69M in Q1 2026.
What does service — revenue mean?
This metric represents the total revenue generated from providing specialized proteomics services to customers, excluding any pass-through taxes. It captures the income derived from the application of the company's proprietary NULISA technology and Precision Proteomics platform on behalf of third-party clients. This revenue stream reflects the commercial adoption and demand for the company's analytical capabilities as a service offering.

Ask your AI about Alamar Biosciences's service — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude